PA
Perceptive Advisors Portfolio holdings
AUM
$5.46B
1-Year Est. Return
264.28%
This Fund
S&P 500
1 Year Est. Return
+264.28%
AUM
$5.46B
AUM Growth
+$2B
(+58%)
Holding
131
Top Buys
| 1 | +$80.3M | |
| 2 | +$65.6M | |
| 3 | +$61.6M | |
| 4 |
Exact Sciences
EXAS
|
+$59M |
| 5 |
Dyne Therapeutics
DYN
|
+$55.6M |
Top Sells
| 1 | +$127M | |
| 2 | +$101M | |
| 3 | +$80M | |
| 4 |
VRNA
Verona Pharma
VRNA
|
+$55.9M |
| 5 |
AKRO
Akero Therapeutics
AKRO
|
+$53.9M |
Sector Composition
| 1 | Healthcare | 99.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
126
Pyxis Oncology
PYXS
$92.8M
| – | – |
-1,178,307
|
|
||
127
uniQure
QURE
$563M
| – | – |
-20,000
|
|
||
|
SCPH
128
DELISTED
scPharmaceuticals
SCPH
| – | – |
-583,142
|
|
||
129
ARS Pharmaceuticals
SPRY
$894M
| – | – |
0
|
|
||
|
TRIB
130
Trinity Biotech
TRIB
$13.1M
| – | – |
-1,790,000
|
|